These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 29898764)

  • 1. Anti-carbamylated protein antibodies as a new biomarker of erosive joint damage in systemic lupus erythematosus.
    Ceccarelli F; Perricone C; Colasanti T; Massaro L; Cipriano E; Pendolino M; Natalucci F; Mancini R; Spinelli FR; Valesini G; Conti F; Alessandri C
    Arthritis Res Ther; 2018 Jun; 20(1):126. PubMed ID: 29898764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers of erosive arthritis in systemic lupus erythematosus: Application of machine learning models.
    Ceccarelli F; Sciandrone M; Perricone C; Galvan G; Cipriano E; Galligari A; Levato T; Colasanti T; Massaro L; Natalucci F; Spinelli FR; Alessandri C; Valesini G; Conti F
    PLoS One; 2018; 13(12):e0207926. PubMed ID: 30513105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-carbamylated protein antibodies in systemic lupus erythematosus patients with articular involvement.
    Massaro L; Ceccarelli F; Colasanti T; Pendolino M; Perricone C; Cipriano E; Natalucci F; Capalbo G; Lucchetti R; Pecani A; Vomero M; Mancini R; Spinelli FR; Alessandri C; Valesini G; Conti F
    Lupus; 2018 Jan; 27(1):105-111. PubMed ID: 28592200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies against carbamylated proteins and cyclic citrullinated peptides in systemic lupus erythematosus: results from two well-defined European cohorts.
    Ziegelasch M; van Delft MA; Wallin P; Skogh T; Magro-Checa C; Steup-Beekman GM; Trouw LA; Kastbom A; Sjöwall C
    Arthritis Res Ther; 2016 Dec; 18(1):289. PubMed ID: 27912793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence, sensitivity and specificity of antibodies against carbamylated proteins in a monocentric cohort of patients with rheumatoid arthritis and other autoimmune rheumatic diseases.
    Pecani A; Alessandri C; Spinelli FR; Priori R; Riccieri V; Di Franco M; Ceccarelli F; Colasanti T; Pendolino M; Mancini R; Truglia S; Barbati C; Vomero M; Sabatinelli D; Morello F; Valesini G; Conti F
    Arthritis Res Ther; 2016 Nov; 18(1):276. PubMed ID: 27887639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of the Presence of Anti-Carbamylated Protein Antibodies in Early Arthritis With a Poorer Clinical and Radiologic Outcome: Data From the French ESPOIR Cohort.
    Truchetet ME; Dublanc S; Barnetche T; Vittecoq O; Mariette X; Richez C; Blanco P; Mahler M; Contin-Bordes C; Schaeverbeke T;
    Arthritis Rheumatol; 2017 Dec; 69(12):2292-2302. PubMed ID: 28853240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies against carbamylated vimentin exist in systemic lupus erythematosus and correlate with disease activity.
    Li Y; Jia R; Liu Y; Tang S; Ma X; Shi L; Zhao J; Hu F; Li Z
    Lupus; 2020 Mar; 29(3):239-247. PubMed ID: 31930936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The isotype and IgG subclass distribution of anti-carbamylated protein antibodies in rheumatoid arthritis patients.
    van Delft MAM; Verheul MK; Burgers LE; Derksen VFAM; van der Helm-van Mil AHM; van der Woude D; Huizinga TWJ; Toes REM; Trouw LA
    Arthritis Res Ther; 2017 Aug; 19(1):190. PubMed ID: 28810902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Carbamylated Protein Antibodies in ACPA-Negative and ACPA-Positive Patients with Rheumatoid Arthritis.
    Dibrov DA; Avdeeva AS; Diatroptov ME; Nasonov EL
    Dokl Biochem Biophys; 2024 Aug; 517(1):235-242. PubMed ID: 39002007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus patients with articular involvement: a predictive marker for erosive disease?
    Taraborelli M; Inverardi F; Fredi M; Ceribelli A; Cavazzana I; Tincani A; Franceschini F
    Reumatismo; 2012 Dec; 64(5):321-5. PubMed ID: 23256108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Jaccoud's arthropathy in systemic lupus erythematosus: clinical, laboratory and ultrasonographic features.
    Ceccarelli F; Massaro L; Perricone C; Pendolino M; Cipriano E; Truglia S; Miranda F; Spinelli FR; Alessandri C; Valesini G; Conti F
    Clin Exp Rheumatol; 2017; 35(4):674-677. PubMed ID: 28339366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of erosive phenotypes in lupus arthritis using magnetic resonance imaging and anti-citrullinated protein antibody, anti-RA33 and RF autoantibody status.
    Ball EM; Tan AL; Fukuba E; McGonagle D; Grey A; Steiner G; Bell AL; Rooney MR
    Rheumatology (Oxford); 2014 Oct; 53(10):1835-43. PubMed ID: 24850876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What can we learn from the presence of anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus?
    Zhao Y; Li J; Li XX; Li C; Li L; Li ZG
    Joint Bone Spine; 2009 Oct; 76(5):501-7. PubMed ID: 19289297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erosive arthritis in systemic lupus erythematosus: not only Rhupus.
    Ceccarelli F; Natalucci F; Olivieri G; Perricone C; Pirone C; Spinelli FR; Alessandri C; Conti F
    Lupus; 2021 Nov; 30(13):2029-2041. PubMed ID: 34666547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-carbamylated protein antibodies precede disease onset in monkeys with collagen-induced arthritis.
    Verheul MK; Vierboom MPM; 't Hart BA; Toes REM; Trouw LA
    Arthritis Res Ther; 2017 Nov; 19(1):246. PubMed ID: 29096669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Citrulline dependence of anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus as a marker of deforming/erosive arthritis.
    Kakumanu P; Sobel ES; Narain S; Li Y; Akaogi J; Yamasaki Y; Segal MS; Hahn PC; Chan EK; Reeves WH; Satoh M
    J Rheumatol; 2009 Dec; 36(12):2682-90. PubMed ID: 19884269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The significance of rheumatoid factor and anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus.
    Popescu C; Zofotă S; Bojincă V; Ionescu R
    Rom J Intern Med; 2013; 51(3-4):179-87. PubMed ID: 24620631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-CarP antibodies as promising marker to measure joint damage and disease activity in patients with rheumatoid arthritis.
    Yee A; Webb T; Seaman A; Infantino M; Meacci F; Manfredi M; Benucci M; Lakos G; Favalli E; Schioppo T; Meroni PL; Mahler M
    Immunol Res; 2015 Feb; 61(1-2):24-30. PubMed ID: 25391608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence of Autoantibodies in Erosive Hand Osteoarthritis and Association with Clinical Presentation.
    van Delft MAM; van Beest S; Kloppenburg M; Trouw LA; Ioan-Facsinay A
    J Rheumatol; 2019 Jan; 46(1):101-105. PubMed ID: 30219766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and prognostic value of anti-CarP antibodies in a sample of Egyptian rheumatoid arthritis patients.
    Elsayed SA; Esmail MA; Ali RM; Mohafez OM
    Clin Rheumatol; 2019 Oct; 38(10):2683-2689. PubMed ID: 31161487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.